Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
22 May 2020
22 May 2020
Historique:
entrez:
9
6
2020
pubmed:
9
6
2020
medline:
9
6
2020
Statut:
epublish
Résumé
During the COVID-19 pandemic, SARS-CoV-2 infected millions of people and claimed hundreds of thousands of lives. Virus entry into cells depends on the receptor binding domain (RBD) of the SARS-CoV-2 spike protein (S). Although there is no vaccine, it is likely that antibodies will be essential for protection. However, little is known about the human antibody response to SARS-CoV-2
Identifiants
pubmed: 32511384
doi: 10.1101/2020.05.13.092619
pmc: PMC7263513
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI078788
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI091707
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI064003
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI111825
Pays : United States
Organisme : NIAID NIH HHS
ID : P50 AI150464
Pays : United States
Commentaires et corrections
Type : UpdateIn
Déclaration de conflit d'intérêts
Declaration of conflict: In connection with this work The Rockefeller University has filed a provisional patent application on which D.F.R. and M.C.N. are inventors.
Références
Nature. 2020 Jul;583(7815):290-295
pubmed: 32422645
Cell Host Microbe. 2016 Sep 14;20(3):392-405
pubmed: 27631702
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):7981-7989
pubmed: 32209664
PLoS Med. 2006 Jul;3(7):e237
pubmed: 16796401
J Immunol Methods. 2008 Jan 1;329(1-2):112-24
pubmed: 17996249
Nat Rev Microbiol. 2013 Dec;11(12):836-48
pubmed: 24217413
Nat Rev Immunol. 2020 Jun;20(6):339-341
pubmed: 32317716
Nature. 2014 Dec 18;516(7531):418-22
pubmed: 25296253
Nature. 2019 Feb;566(7744):393-397
pubmed: 30664748
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
J Exp Med. 2014 Nov 17;211(12):2361-72
pubmed: 25385756
PLoS One. 2012;7(11):e49774
pubmed: 23226220
Sci Immunol. 2018 Feb 16;3(20):
pubmed: 29453292
Science. 2017 Nov 17;358(6365):865-866
pubmed: 29146795
Immunity. 2019 Jun 18;50(6):1513-1529.e9
pubmed: 31126879
Immunity. 2007 Feb;26(2):205-13
pubmed: 17306569
J Immunol Methods. 2020 Mar;478:112734
pubmed: 31866284
Nature. 2009 Apr 2;458(7238):636-40
pubmed: 19287373
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
NPJ Vaccines. 2017 Jul 10;2:19
pubmed: 29263875
Trends Immunol. 2020 May;41(5):355-359
pubmed: 32249063
Nat Protoc. 2016 Oct;11(10):1908-1923
pubmed: 27658009
J Mol Biol. 1982 May 5;157(1):105-32
pubmed: 7108955
J Pathol. 2015 Jan;235(2):185-95
pubmed: 25270030
Cell. 2017 May 04;169(4):597-609.e11
pubmed: 28475892
Science. 2020 May 8;368(6491):630-633
pubmed: 32245784
J Virol. 1986 Aug;59(2):284-91
pubmed: 3016298
Biophys J. 1985 Jan;47(1):61-70
pubmed: 3978191
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12123-8
pubmed: 17620608
Immunol Rev. 2017 Jan;275(1):285-295
pubmed: 28133801
Science. 2011 Sep 16;333(6049):1633-7
pubmed: 21764753
J Struct Biol. 2005 Oct;152(1):36-51
pubmed: 16182563
Bioinformatics. 2015 Oct 15;31(20):3356-8
pubmed: 26069265
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W34-40
pubmed: 23671333
Clin Vaccine Immunol. 2010 Jul;17(7):1055-65
pubmed: 20463105
Nat Med. 2019 Oct;25(10):1589-1600
pubmed: 31591605
PLoS One. 2016 Aug 11;11(8):e0160853
pubmed: 27513338
J Struct Biol. 2007 Jan;157(1):281-7
pubmed: 16963278
Cell. 2019 Feb 21;176(5):1026-1039.e15
pubmed: 30712865